Management of idiopathic pulmonary fibrosis in France: A survey of 1244 pulmonologists

Respiratory Medicine

Volumn 108, Issue 1, 2014, Pages 195-202

  Cottin, V ^a   Cadranel, J ^b   Crestani, B ^c   Dalphin, J C ^d   Delaval, P ^e   Israel Biet, D ^f   Kessler, R ^g   Reynaud Gaubert, M ^h   Valeyre, D ⁱ   Wallaert, B ^j   Bouquillon, B ^k   Cordier, J F ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h University Hospital   (France)

ⁱ UNIVERSITÉ PARIS 13   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k Opened Mind Health   (France)

more..

Author keywords

Drug therapy; Idiopathic pulmonary fibrosis; Management; Pirfenidone; Survey

Indexed keywords

ACETYLCYSTEINE; CARBON MONOXIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; AWARENESS; CLINICAL COMPETENCE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; FRANCE; HUMAN; INCIDENCE; LUNG DIFFUSION CAPACITY; MALE; MIDDLE AGED; PATHOLOGIST; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PULMONOLOGIST; QUESTIONNAIRE; RADIOLOGIST;

DRUG THERAPY; IDIOPATHIC PULMONARY FIBROSIS; MANAGEMENT; PIRFENIDONE; SURVEY;

ADMINISTRATION, ORAL; EARLY DIAGNOSIS; FRANCE; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DIFFUSING CAPACITY; PULMONARY MEDICINE; QUESTIONNAIRES; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84893657711     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.11.017     Document Type: Article

References (23)

1. T.E. King Jr., A. Pardo, and M. Selman Idiopathic pulmonary fibrosis Lancet 378 2011 1949 1961
2. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, J.A. Lasky, D.A. Lynch, J.H. Ryu, J.J. Swigris, A.U. Wells, J. Ancochea, D. Bouros, C. Carvalho, U. Costabel, M. Ebina, D.M. Hansell, T. Johkoh, D.S. Kim, T.E. King Jr., Y. Kondoh, J. Myers, N.L. Muller, A.G. Nicholson, L. Richeldi, M. Selman, R.F. Dudden, B.S. Griss, S.L. Protzko, and H.J. Schunemann An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
3. K.R. Flaherty, T.E. King Jr., G. Raghu, J.P. Lynch 3rd, T.V. Colby, W.D. Travis, B.H. Gross, E.A. Kazerooni, G.B. Toews, Q. Long, S. Murray, V.N. Lama, S.E. Gay, and F.J. Martinez Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170 2004 904 910
4. P. Spagnolo, R.M. du Bois, and V. Cottin Rare (orphan) lung disease and drug development: current status and future challenges Lancet Respir Med 1 2013 479 487
5. L. Nalysnyk, J. Cid-Ruzafa, P. Rotella, and D. Esser Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Eur Respir Rev 21 2012 355 361
6. J. Behr Evidence-based treatment strategies in idiopathic pulmonary fibrosis Eur Respir Rev 22 2013 163 168
7. G. Raghu, K.J. Anstrom, T.E. King Jr., J.A. Lasky, and F.J. Martinez Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis N Engl J Med 366 2012 1968 1977
8. I. Noth, K.J. Anstrom, S.B. Calvert, J. de Andrade, K.R. Flaherty, C. Glazer, R.J. Kaner, and M.A. Olman A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 2012 88 95
9. G. Raghu, J. Behr, K.K. Brown, J.J. Egan, S.M. Kawut, K.R. Flaherty, F.J. Martinez, S.D. Nathan, A.U. Wells, H.R. Collard, U. Costabel, L. Richeldi, J. de Andrade, N. Khalil, L.D. Morrison, D.J. Lederer, L. Shao, X. Li, P.S. Pedersen, A.B. Montgomery, J.W. Chien, and T.G. O'Riordan Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial Ann Intern Med 158 2013 641 649
10. P.W. Noble, C. Albera, W.Z. Bradford, U. Costabel, M.K. Glassberg, D. Kardatzke, T.E. King Jr., L. Lancaster, S.A. Sahn, J. Szwarcberg, D. Valeyre, and R.M. du Bois Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 2011 1760 1769
11. L. Richeldi, U. Costabel, M. Selman, D.S. Kim, D.M. Hansell, A.G. Nicholson, K.K. Brown, K.R. Flaherty, P.W. Noble, G. Raghu, M. Brun, A. Gupta, N. Juhel, M. Kluglich, and R.M. du Bois Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis N Engl J Med 365 2011 1079 1087
12. M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H.M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, A.G. Nicholson, E.K. Verbeken, J. Verschakelen, C.D. Flower, F. Capron, S. Petruzzelli, P. De Vuyst, J.M. van den Bosch, E. Rodriguez-Becerra, G. Corvasce, I. Lankhorst, M. Sardina, and M. Montanari High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242
13. H. Taniguchi, M. Ebina, Y. Kondoh, T. Ogura, A. Azuma, M. Suga, Y. Taguchi, H. Takahashi, K. Nakata, A. Sato, M. Takeuchi, G. Raghu, S. Kudoh, and T. Nukiwa Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 2010 821 829
14. H.R. Collard, J.E. Loyd, T.E. King Jr., and L.H. Lancaster Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians Respir Med 101 2007 2011 2016
15. C.M. Smith, and K.M. Moser Management for interstitial lung disease. State of the art Chest 95 1989 676 678
16. I.D. Johnston, S.A. Gomm, S. Kalra, A.A. Woodcock, C.C. Evans, and C.R. Hind The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom Eur Respir J 6 1993 891 893
17. T. Peikert, C.E. Daniels, T.J. Beebe, K.C. Meyer, and J.H. Ryu Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis Respir Med 102 2008 1342 1348
18. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
19. A.U. Wells Managing diagnostic procedures in idiopathic pulmonary fibrosis Eur Respir Rev 22 2013 158 162
20. G. Schoenheit, I. Becattelli, and A.H. Cohen Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients Chronic Resp Dis 8 2011 225 231
21. D.J. Lamas, S.M. Kawut, E. Bagiella, N. Philip, S.M. Arcasoy, and D.J. Lederer Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study Am J Respir Crit Care Med 184 2011 842 847
22. J.F. Cordier, and V. Cottin Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis Eur Respir J 42 2013 916 923
23. V. Cottin, B. Crestani, D. Valeyre, B. Wallaert, J. Cadranel, J.C. Dalphin, P. Delaval, D. Israel-Biet, R. Kessler, M. Reynaud-Gaubert, and J.F. Cordier Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique. Élaborées par le centre national de référence et les centres de compétence pour les maladies pulmonaires rares sous l'égide de la Société de pneumologie de langue française Rev Mal Respir 2013 10.1016/j.rmr.2013. 09.007 [in press]